NCT00034125已完成3 期
a Phase 3 Randomized Double Blind Evaluation of LY353381 Compared With Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 11
研究概览
简要总结
To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (11)
Loading locations...
相似试验
暂停
3 期
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In SituNCT06671912Alliance for Clinical Trials in Oncology1,556
Unknown
3 期
A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung CancerNon Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer RecurrentNCT03533127Luye Pharma Group Ltd.648
已完成
1 期
A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PDParkinson DiseaseNCT04630860Luye Pharma Group Ltd.30
已完成
3 期
Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive PatientsEarly-stage Breast CancerNCT00309491Austrian Breast & Colorectal Cancer Study Group2,021
进行中（未招募）
3 期
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerBreast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast CarcinomaMultifocal Breast CarcinomaSynchronous Bilateral Breast CarcinomaNCT01272037National Cancer Institute (NCI)5,018